NanoCarrier Co., Ltd.

TSE:4571.T

167 (JPY) • At close November 5, 2024
Bedrijfsnaam NanoCarrier Co., Ltd.
Symbool 4571.T
Munteenheid JPY
Prijs 166
Beurswaarde 11,721,935,786
Dividendpercentage 0%
52-weken bereik 135 - 259
Industrie Biotechnology
Sector Healthcare
CEO Dr. Shiro Akinaga Ph.D.
Website https://www.nanocarrier.co.jp

An error occurred while fetching data.

Over NanoCarrier Co., Ltd.

NanoCarrier Co., Ltd. researches, develops, produces, and sells pharmaceuticals using micelle nanoparticle technology primarily for the treatment of cancer in Japan. The company's product pipeline includes VB-111 non-proliferative adenovirus vector, which is in phase III clinical trials for the treatment of ovarian cancer, as well as in phase II clinical

Vergelijkbare Aandelen

FINDEX Inc. logo

FINDEX Inc.

3649.T

870 JPY

Daiken Medical Co., Ltd. logo

Daiken Medical Co., Ltd.

7775.T

500 JPY

RaQualia Pharma Inc. logo

RaQualia Pharma Inc.

4579.T

484 JPY

ReproCELL Incorporated logo

ReproCELL Incorporated

4978.T

106 JPY

JMS Co.,Ltd. logo

JMS Co.,Ltd.

7702.T

468 JPY

Medical System Network Co., Ltd. logo

Medical System Network Co., Ltd.

4350.T

408 JPY

Astena Holdings Co., Ltd. logo

Astena Holdings Co., Ltd.

8095.T

514 JPY

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,794 JPY

OncoTherapy Science, Inc. logo

OncoTherapy Science, Inc.

4564.T

32 JPY

3-D Matrix, Ltd. logo

3-D Matrix, Ltd.

7777.T

110 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)